Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct 26;96(22):12731-6.
doi: 10.1073/pnas.96.22.12731.

Nrf2 is essential for protection against acute pulmonary injury in mice

Affiliations

Nrf2 is essential for protection against acute pulmonary injury in mice

K Chan et al. Proc Natl Acad Sci U S A. .

Abstract

Nrf2 is a member of the "cap 'n' collar" family of transcription factors. These transcription factors bind to the NF-E2 binding sites (GCTGAGTCA) that are essential for the regulation of erythroid-specific genes. Nrf2 is expressed in a wide range of tissues, many of which are sites of expression for phase 2 detoxification genes. Nrf2(-/-) mice are viable and have a normal phenotype under normal laboratory conditions. The NF-E2 binding site is a subset of the antioxidant response elements that have the sequence GCNNNGTCA. The antioxidant response elements are regulatory sequences found on promoters of several phase 2 detoxification genes that are inducible by xenobiotics and antioxidants. We report here that Nrf2(-/-) mice are extremely susceptible to the administration of the antioxidant butylated hydroxytoluene. With doses of butylated hydroxytoluene that are tolerated by wild-type mice, the Nrf2(-/-) mice succumb from acute respiratory distress syndrome. Gene expression studies show that the expression of several detoxification enzymes is altered in the Nrf2(-/-) mice. The Nrf2(-/-) mice may prove to be a good in vivo model for toxicological studies. As oxidative damage causes DNA breakage, these mice may also be useful for testing carcinogenic agents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival rate of wild-type and Nrf2−/− mice given BHT. Solid lines represent the wild-type mice; broken lines represent the Nrf2−/− mice. (A and B) Mice were fed 0.5% BHT (n = 36 for wild-type and Nrf2−/− mice) or 1% BHT (n = 48 for wild-type mice, and n = 46 for Nrf2−/− mice). (C and D) i.p. injection of 600 mg of BHT per kg of body weight (n = 12 for wild-type mice, and n = 13 for Nrf2−/− mice) or 700 mg of BHT per kg of body weight (n = 12 for wild-type mice, and n = 11 for Nrf2−/− mice). P.O., per os.
Figure 2
Figure 2
Photomicrographs of lungs at day 5 of 1% dietary BHT. (A and B) No difference is found between the lungs of untreated wild-type (Nrf2+/+) and Nrf2−/− mice. (C) The lung of a wild-type mouse fed 1% BHT shows thickening of the alveolar septa and some congestion. (D) In the lung of a mouse fed BHT, the alveolar architecture is mostly destroyed; extensive capillary damage was evident, and erythrocytes are found in the alveolar space. (Bars = 50 μm.)
Figure 3
Figure 3
LD50 and LD100 values for Nrf2−/− injected i.p. with BHT. Solid line, wild-type mice; broken line, Nrf2−/− mice. The LD50 and LD100 of Nrf2−/− are 530 mg/kg and 660 mg/kg, respectively.
Figure 4
Figure 4
Localization of Nrf2 mRNA in adult intestine. In situ hybridization was performed on sections of adult intestine by using antisense probe (Left) and sense probe (Right). Each section is shown under brightfield (Upper) and darkfield (Lower) illumination. l, lumen; v, villi; g, intestinal gland; m, muscle. (Bars = 100 μm.)
Figure 5
Figure 5
Northern blot analyses of differentially expressed genes in the lungs. The ratios of gene expressions between the Nrf2−/− mice and wild-type mice shown are calculated after normalization to their respective β-actin gene expression. WT, wild type.

References

    1. Tuan D, Solomon W, Li Q, London I M. Proc Natl Acad Sci USA. 1985;82:6384–6388. - PMC - PubMed
    1. Forrester W C, Thompson C, Elder J T, Groudine M. Proc Natl Acad Sci USA. 1986;83:1359–1363. - PMC - PubMed
    1. Forrester W C, Takegawa S, Papayannopoulou T, Stamatoyannopoulos G, Groudine M. Nucleic Acids Res. 1987;15:10159–10177. - PMC - PubMed
    1. Collis P, Antoniou M, Grosveld F. EMBO J. 1990;9:233–240. - PMC - PubMed
    1. Moi P, Kan Y W. Proc Natl Acad Sci USA. 1990;87:9000–9004. - PMC - PubMed

Publication types